| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Nikolic Boris serves as a Director at EDIT. Across recent SEC filings that breaks down to 1 buy and 0 sells. Those positions are worth an estimated $103K at current prices.
The biggest single holding is EDIT (~$103K) as Director. Net of sales, the recent Form 4 record there shows accumulation of 35,000 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Jun 2, 2017 | EDIT Editas Medicine, Inc. | Director | Buy | 35,000 | $14.07 | $492,527.00 | New |